Main sector:
Biotechnology - Therapeutics and Diagnostics
Subsectors:
Drug delivery
Peptides
Small molecules
Indications:
Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Digestive system / gastroenterology
Products
In development: 11
Description:
Zealand Pharma is a biotechnology company that discovers, designs, and develops peptide-based medicines. The company's product Petrelintide is an investigational long-acting amylin analog for once-weekly subcutaneous administration that has been designed with chemical and physical stability at neutral pH, minimizing fibrillation and allowing for co-formulation with other peptides. The company's other product Dapiglutide is an investigational long-acting GLP-1/GLP-2 receptor dual agonist for...
